Olmesartan Medoxomil Tablet
Product Images NDC 72603-950

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Olmesartan Medoxomil (NDC 72603-950). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Northstar Rxllc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure (Olmesartan Medoxomil Figure)

Figure (Olmesartan Medoxomil Figure)
A dose-response line graph illustrating the placebo-adjusted reduction in blood pressure (mmHg) by Olmesartan Medoxomil doses (mg). The y-axis shows reduction in blood pressure, and the x-axis shows Olmesartan Medoxomil dose in mg. Data series represent reductions in systolic and diastolic blood pressure at varying doses.*
FDA Label Image

333 (Olmesartan Structure)

333 (Olmesartan Structure)
Chemical structure of Olmesartan medoxomil, showing its molecular framework with characteristic cyclic and functional groups as part of the oral tablet's active ingredient.*
FDA Label Image

009 (Olmesartan Tablets 20mg 30s)

009 (Olmesartan Tablets 20mg 30s)
Label for Olmesartan Medoxomil Tablets, USP 20 mg oral tablets, containing 30 tablets per package. The label includes storage instructions, dosage information, and manufacturing details indicating NorthStar Rx LLC as the labeler and Macleods Pharmaceuticals Ltd. in India as the manufacturer. The label features a blue and white color scheme with the concentration prominently displayed in a green box.*
FDA Label Image

112 (Olmesartan Tablets 20mg 90s)

112 (Olmesartan Tablets 20mg 90s)
Label for Olmesartan Medoxomil Tablets, USP 20 mg, oral tablet form. The label indicates a bottle containing 90 tablets. It shows the manufacturer as NorthStar Rx LLC, Memphis, TN, with Macleods Pharmaceuticals Ltd. in India as the manufacturer. The label includes dosage storage instructions and NDC 72603-951-02.*
FDA Label Image

676 (Olmesartan Tablets 40mg 30s)

676 (Olmesartan Tablets 40mg 30s)
Label for Olmesartan Medoxomil Tablets, USP 40 mg oral tablets, containing 30 tablets per container. The label shows the NorthStar Rx LLC brand, manufacturer information including Macleods Pharmaceuticals Ltd., and storage instructions. The NDC code and expiration date (04/2026) are also visible.*
FDA Label Image

889 (Olmesartan Tablets 40mg 90s)

889 (Olmesartan Tablets 40mg 90s)
Label for Olmesartan Medoxomil Tablets, USP 40 mg oral tablets, containing 90 tablets. The label shows the NDC number 72603-952-02 and notes the storage temperature and usual dosage instructions. The product is manufactured for Northstar Rx LLC, Memphis, TN, and by Macleods Pharmaceuticals Ltd., India.*
FDA Label Image

556 (Olmesartan Tablets 5mg 30s)

556 (Olmesartan Tablets 5mg 30s)
Label for Olmesartan Medoxomil Tablets USP 5 mg, supplied by NorthStar RxLLC. The label indicates a package of 30 oral tablets. Storage instructions specify maintaining a temperature of 20° to 25°C with allowable excursions to 15° to 30°C. The product is manufactured by Macleods Pharmaceuticals Ltd. in India, with NorthStar RxLLC as the labeler in Memphis, TN.*
FDA Label Image

445 (Olmesartan Tablets 5mg 90s)

445 (Olmesartan Tablets 5mg 90s)
Label for Olmesartan Medoxomil Tablets USP 5 mg, oral tablets, with a quantity of 90 tablets. The label includes manufacturer information: NorthStar Rx LLC, Memphis, TN, and Macleods Pharmaceuticals Ltd., Baddi, India. It displays storage instructions and the product's expiration date of 04/2026. The label contains barcodes and the product NDC 72603-950-02.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.